Studies on the immunohistochemistry of colon cancer also revealed that the low expression of MUC2 is associated with colon tumor and less favorable disease outcome, and lack of expression of MUC5AC and MUC6 were associated with worsened stages of CRC [149]. Here, MUC5AC is linked to colonic neoplasm.